Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BioAge Labs (BIOA)

BioAge Labs Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BIOA
DateTimeSourceHeadlineSymbolCompany
06/12/202421:35GlobeNewswire Inc.BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of ObesityNASDAQ:BIOABioAge Labs Inc
05/12/202421:30GlobeNewswire Inc.BioAge Labs to Present at Goldman Sachs “Year-Ahead” Catalyst ClinicNASDAQ:BIOABioAge Labs Inc
21/11/202421:30GlobeNewswire Inc.BioAge Labs to Present at Upcoming Investor ConferencesNASDAQ:BIOABioAge Labs Inc
07/11/202421:30GlobeNewswire Inc.BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:BIOABioAge Labs Inc
04/11/202414:00GlobeNewswire Inc.BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024NASDAQ:BIOABioAge Labs Inc
24/10/202413:00GlobeNewswire Inc.BioAge Labs to Present at Jefferies London Healthcare ConferenceNASDAQ:BIOABioAge Labs Inc
01/10/202420:30GlobeNewswire Inc.BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares and Closing of the Concurrent Private PlacementNASDAQ:BIOABioAge Labs Inc
26/09/202400:00GlobeNewswire Inc.BioAge Labs Announces Pricing of Upsized Initial Public OfferingNASDAQ:BIOABioAge Labs Inc
 Showing the most relevant articles for your search:NASDAQ:BIOA